Literature DB >> 25961362

Predicting Incongruence between Self-reported and Documented Colorectal Cancer Screening in a Sample of African American Medicare Recipients.

Mark Manning1, Janice Burnett2, Robert Chapman2.   

Abstract

Assessments of colorectal cancer (CRC) screening rates typically rely on self-reported screening data, which are often incongruent with medical records. We used multilevel models to examine health-related, socio-demographic and psychological predictors of incongruent self-reports for CRC screening among Medicare-insured African Americans (N = 3,740). Results indicated that living alone decreased, and income increased, the odds of congruently self-reporting endoscopic CRC screening. Being male and having greater number of comorbidities decreased, and having less than a high school education increased, the odds of congruently self-reported fecal occult blood tests. Living alone, age and income had the most robust effects across classifications into one of four mutually exclusive categories defined by screening status (screened/unscreened) and congruence of self-reports. The results underscore the clinical importance of gathering socio-demographic data via patient interviews, and the relevance of these data for judging the veracity of self-reported CRC screenings behaviors.

Entities:  

Keywords:  African Americans; colorectal cancer screening; self-report incongruence; socio-demographics

Mesh:

Year:  2015        PMID: 25961362      PMCID: PMC4641836          DOI: 10.1080/08964289.2015.1011600

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  41 in total

1.  Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization.

Authors:  M T Mandelson; A Z LaCroix; L A Anderson; M R Nadel; N C Lee
Journal:  Am J Epidemiol       Date:  1999-09-15       Impact factor: 4.897

2.  American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008.

Authors:  Oralia Garcia Dominic; Thomas McGarrity; Mark Dignan; Eugene J Lengerich
Journal:  Am J Gastroenterol       Date:  2009-10       Impact factor: 10.864

3.  Mammography use among sociodemographically diverse women: the accuracy of self-report.

Authors:  J G Zapka; C Bigelow; T Hurley; L D Ford; J Egelhofer; W M Cloud; E Sachsse
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

4.  Attitudes toward colorectal cancer screening tests.

Authors:  B S Ling; M A Moskowitz; D Wachs; B Pearson; P C Schroy
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

5.  Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening.

Authors:  Nasar U Ahmed; Valerie Pelletier; Kelly Winter; Ahmed N Albatineh
Journal:  Am J Public Health       Date:  2013-05-16       Impact factor: 9.308

Review 6.  Agreement between self-reported and registered colorectal cancer screening: a meta-analysis.

Authors:  D Dodou; J C F de Winter
Journal:  Eur J Cancer Care (Engl)       Date:  2014-04-23       Impact factor: 2.520

7.  Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population.

Authors:  Stephen J McPhee; Tung T Nguyen; Sarah J Shema; Bang Nguyen; Carol Somkin; Phuong Vo; Rena Pasick
Journal:  Prev Med       Date:  2002-11       Impact factor: 4.018

8.  Patients whose physicians recommend colonoscopy and those who follow through.

Authors:  Jeanette M Daly; Yinghui Xu; Barcey T Levy
Journal:  J Prim Care Community Health       Date:  2012-11-04

9.  Colorectal cancer screening among men and women in the United States.

Authors:  Neeraja B Peterson; Harvey J Murff; Reid M Ness; Robert S Dittus
Journal:  J Womens Health (Larchmt)       Date:  2007 Jan-Feb       Impact factor: 2.681

10.  Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative.

Authors:  J L Richardson; K Danley; G T Mondrus; D Deapen; T Mack
Journal:  Prev Med       Date:  1995-03       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.